Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,448 total, page 17 of 29
Google Health Search Trial
NCT03073746
Optimal Method for Mydriasis in Cataract Surgery
NCT02909140
Exercise and Cognition Trials
NCT02958735
Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment
NCT02365870
Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients
NCT02781649
Metabolic Impact of Intermittent CPAP
NCT02824263
Trial of Integrated Smoking Cessation, Exercise and Weight Management in Serious Mental Illness: TRIUMPH
NCT02424188
Healthy Behaviors Learning Task and Sleep
NCT02910648
Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection
NCT02707991
Understanding the Urine Electrolyte Profile of the Individual Renal Unit
NCT02837393
Pregnancy and Anxious Thoughts: The Role of the Immune and Endocrine Systems
NCT03664128
Pharmacokinetic and Pharmacodynamic Effects of Smoked and Vaporized Cannabis
NCT03676166
Stimulating Language in Subacute StrokE
NCT02674490
SOCIABLE Seniors Optimizing Community Integration to Advance Better Living With ESRD
NCT03055273
SteadyRx: Smartphone ART Adherence Intervention for Drug Users
NCT02317614
Community Supported Risk Reduction for Syringe Exchange Participants
NCT02654366
Stress & Premenstrual Symptoms Study
NCT02777372
Safety Study of Acellular Adipose Tissue for Soft Tissue Reconstruction
NCT02817984
Fractional Laser Assisted Steroid Therapy vs Intralesional Steroids in the Treatment of Keloids
NCT02996097
Pathophysiology of Paget's Disease of Bone
NCT02802384
Community-Based Cervical Cancer Prevention and Education Among Women Living With HIV
NCT03033888
Liposomal Bupivacaine for Pain Control After Total Shoulder Arthroplasty
NCT02762071
The Substrate and Intervention Mechanisms for Persistent Atrial Fibrillation Trial
NCT02918396
Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender Women
NCT03060785
The Platelet Aggregation After tiCagrelor Inhibition and FentanYl Trial (PACIFY)
NCT02683707
Timolol for the Treatment of Acne and Rosacea
NCT02774590
Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma
NCT02974764
Effect of Transcranial Direct Current Stimulation on Peripheral Neuropathy
NCT03073759
Early Speech With One-Way Speaking Valve in Tracheostomy Patients
NCT03008174
Salud al Día: Engaging Latino Parents in Pediatric Primary Care
NCT02647814
Sub-Q Versus IV Furosemide in Acute Heart Failure
NCT02579057
Normal Saline Use With Suctioning
NCT02612961
Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses
NCT02276963
A Pilot Study of Intermittent Calorie Restriction in Multiple Sclerosis
NCT02647502
Answer ALS: Individualized Initiative for ALS Discovery
NCT02574390
Evaluating Muscle Weakness Improvement With Lorcaserin in ICU
NCT02523690
ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir
NCT02609399
Community Central Line Infection Prevention Trial
NCT02351258
Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients
NCT02602262
Suppression of HIV 1 RNA in People Living With HIV
NCT02363387
The Long-Term Treatment of Drug Addiction and Unemployment
NCT02487745
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
NCT02624180
Vitreous Surgery With Intraocular Assistance
NCT02574624
Shaping Anesthetic Techniques to Reduce Post-operative Delirium
NCT03133845
Transcranial Direct Current Stimulation and Autism
NCT01603225
Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being
NCT02536352
Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma
NCT02687139
Pre to Postoperative Smoking Cessation
NCT02683161
Intravenous Clonidine for Sedation in Infants and Children Who Are Mechanically Ventilated - Dosing Finding Study
NCT02249039
Efficacy and Safety of Pregabalin in Treatment of Neuropathic Pain in Patients With Idiopathic Small Fiber Neuropathy
NCT02607254
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.